Loading…
Ormond's disease - the current state of knowledge about diagnosis and treatment
Introduction: Retroperitoneal fibrosis (Ormond's disease; RPF) is a rare condition characterized by chronic inflammation and resulting progressive fibrosis of the retroperitoneal space. Due to its low prevalence and uncharacteristic symptoms, it is often overlooked in the diagnostic process, re...
Saved in:
Published in: | Journal of education, health and sport health and sport, 2022-09, Vol.12 (9), p.599-606 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 606 |
container_issue | 9 |
container_start_page | 599 |
container_title | Journal of education, health and sport |
container_volume | 12 |
creator | Dankiewicz, Sara Bróż, Sebastian Żelazny, Przemysław Filipczak, Joanna Swora, Aleksandra Borowik, Joanna Sygacz, Oliwer Brodowski, Wojciech Pawłowski, Piotr Basta-Arciszewska, Katarzyna |
description | Introduction: Retroperitoneal fibrosis (Ormond's disease; RPF) is a rare condition characterized by chronic inflammation and resulting progressive fibrosis of the retroperitoneal space. Due to its low prevalence and uncharacteristic symptoms, it is often overlooked in the diagnostic process, resulting in a late-stage diagnosis when complications are already present and treatment options are limited.
The aim of the study: The purpose of our study was to present, based on the available literature, the latest reports on the diagnosis and treatment of Ormond disease.
State of knowledge: The diagnosis of RPF is based on an anamnesis and imaging. Sometimes a surgical biopsy of the fibrous tissue is necessary. The pathogenesis remains partly unclear. There is no characteristic laboratory marker for early diagnosis of the disease. It is important to distinguish the primary form from the secondary form, in which the trigger factors are known. In therapy, steroid therapy is still the standard. Attempts are being made to treat with other immunosuppressants and biologic drugs with good results, which speaks to the autoimmune basis of the disease. In some cases, surgical treatment and removal of fibrous tissue compressing abdominal structures is essential.
Summary: Although the state of knowledge about retroperitoneal fibrosis has been greatly expanded in recent years, many questions remain to be clarified, especially about its pathogenesis and possible early clinical clues to facilitate diagnosis. |
doi_str_mv | 10.12775/JEHS.2022.12.09.071 |
format | article |
fullrecord | <record><control><sourceid>doaj_cross</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2db7ce992ff74d1db49765260d3eecae</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_2db7ce992ff74d1db49765260d3eecae</doaj_id><sourcerecordid>oai_doaj_org_article_2db7ce992ff74d1db49765260d3eecae</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1571-70b2da4b5fb69319e1d2dcd495775556f88418658fbc199ada7c4f2b8c95d7c53</originalsourceid><addsrcrecordid>eNpNkE1LAzEQhoMoWGr_gYfcPO2aZDebzVFKtZXCHtRzyMekbm03kqSI_95tK-Jp5h1mHpgHoVtKSsqE4PfPi-VLyQhjYy6JLImgF2jCKkmLtiLN5b_-Gs1S2hJCaMMp5WSCui7uw-DuEnZ9Ap0AFzi_A7aHGGHIOGWdAQePP4bwtQO3AaxNOORxXW-GkPqE9eBwjqDzfjy4QVde7xLMfusUvT0uXufLYt09reYP68JSLmghiGFO14Z708iKSqCOOetqycePOG9829a0bXjrjaVSaqeFrT0zrZXcCcurKVqduS7orfqM_V7HbxV0r06DEDdKx9zbHSjmjLAgJfNe1I46U0vRcNYQVwFYDSOrPrNsDClF8H88StTJsTo6VkfHY1ZEqtFx9QN7dW-0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Ormond's disease - the current state of knowledge about diagnosis and treatment</title><source>Open Access: DOAJ - Directory of Open Access Journals</source><creator>Dankiewicz, Sara ; Bróż, Sebastian ; Żelazny, Przemysław ; Filipczak, Joanna ; Swora, Aleksandra ; Borowik, Joanna ; Sygacz, Oliwer ; Brodowski, Wojciech ; Pawłowski, Piotr ; Basta-Arciszewska, Katarzyna</creator><creatorcontrib>Dankiewicz, Sara ; Bróż, Sebastian ; Żelazny, Przemysław ; Filipczak, Joanna ; Swora, Aleksandra ; Borowik, Joanna ; Sygacz, Oliwer ; Brodowski, Wojciech ; Pawłowski, Piotr ; Basta-Arciszewska, Katarzyna</creatorcontrib><description>Introduction: Retroperitoneal fibrosis (Ormond's disease; RPF) is a rare condition characterized by chronic inflammation and resulting progressive fibrosis of the retroperitoneal space. Due to its low prevalence and uncharacteristic symptoms, it is often overlooked in the diagnostic process, resulting in a late-stage diagnosis when complications are already present and treatment options are limited.
The aim of the study: The purpose of our study was to present, based on the available literature, the latest reports on the diagnosis and treatment of Ormond disease.
State of knowledge: The diagnosis of RPF is based on an anamnesis and imaging. Sometimes a surgical biopsy of the fibrous tissue is necessary. The pathogenesis remains partly unclear. There is no characteristic laboratory marker for early diagnosis of the disease. It is important to distinguish the primary form from the secondary form, in which the trigger factors are known. In therapy, steroid therapy is still the standard. Attempts are being made to treat with other immunosuppressants and biologic drugs with good results, which speaks to the autoimmune basis of the disease. In some cases, surgical treatment and removal of fibrous tissue compressing abdominal structures is essential.
Summary: Although the state of knowledge about retroperitoneal fibrosis has been greatly expanded in recent years, many questions remain to be clarified, especially about its pathogenesis and possible early clinical clues to facilitate diagnosis.</description><identifier>ISSN: 2391-8306</identifier><identifier>EISSN: 2391-8306</identifier><identifier>DOI: 10.12775/JEHS.2022.12.09.071</identifier><language>eng</language><publisher>Kazimierz Wielki University</publisher><subject>glucocorticosteroid therapy ; IgG4-related disease ; immunosuppressive treatment ; Ormond's disease ; retroperitoneal fibrosis</subject><ispartof>Journal of education, health and sport, 2022-09, Vol.12 (9), p.599-606</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-0756-387X ; 0000-0002-6171-0386 ; 0000-0002-3512-8368 ; 0000-0002-7759-1588 ; 0000-0003-3245-945X ; 0000-0001-6794-9112 ; 0000-0002-6191-2535 ; 0000-0002-9208-8462 ; 0000-0001-8369-6207 ; 0000-0002-1197-7218</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,2102,27924,27925</link.rule.ids></links><search><creatorcontrib>Dankiewicz, Sara</creatorcontrib><creatorcontrib>Bróż, Sebastian</creatorcontrib><creatorcontrib>Żelazny, Przemysław</creatorcontrib><creatorcontrib>Filipczak, Joanna</creatorcontrib><creatorcontrib>Swora, Aleksandra</creatorcontrib><creatorcontrib>Borowik, Joanna</creatorcontrib><creatorcontrib>Sygacz, Oliwer</creatorcontrib><creatorcontrib>Brodowski, Wojciech</creatorcontrib><creatorcontrib>Pawłowski, Piotr</creatorcontrib><creatorcontrib>Basta-Arciszewska, Katarzyna</creatorcontrib><title>Ormond's disease - the current state of knowledge about diagnosis and treatment</title><title>Journal of education, health and sport</title><description>Introduction: Retroperitoneal fibrosis (Ormond's disease; RPF) is a rare condition characterized by chronic inflammation and resulting progressive fibrosis of the retroperitoneal space. Due to its low prevalence and uncharacteristic symptoms, it is often overlooked in the diagnostic process, resulting in a late-stage diagnosis when complications are already present and treatment options are limited.
The aim of the study: The purpose of our study was to present, based on the available literature, the latest reports on the diagnosis and treatment of Ormond disease.
State of knowledge: The diagnosis of RPF is based on an anamnesis and imaging. Sometimes a surgical biopsy of the fibrous tissue is necessary. The pathogenesis remains partly unclear. There is no characteristic laboratory marker for early diagnosis of the disease. It is important to distinguish the primary form from the secondary form, in which the trigger factors are known. In therapy, steroid therapy is still the standard. Attempts are being made to treat with other immunosuppressants and biologic drugs with good results, which speaks to the autoimmune basis of the disease. In some cases, surgical treatment and removal of fibrous tissue compressing abdominal structures is essential.
Summary: Although the state of knowledge about retroperitoneal fibrosis has been greatly expanded in recent years, many questions remain to be clarified, especially about its pathogenesis and possible early clinical clues to facilitate diagnosis.</description><subject>glucocorticosteroid therapy</subject><subject>IgG4-related disease</subject><subject>immunosuppressive treatment</subject><subject>Ormond's disease</subject><subject>retroperitoneal fibrosis</subject><issn>2391-8306</issn><issn>2391-8306</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpNkE1LAzEQhoMoWGr_gYfcPO2aZDebzVFKtZXCHtRzyMekbm03kqSI_95tK-Jp5h1mHpgHoVtKSsqE4PfPi-VLyQhjYy6JLImgF2jCKkmLtiLN5b_-Gs1S2hJCaMMp5WSCui7uw-DuEnZ9Ap0AFzi_A7aHGGHIOGWdAQePP4bwtQO3AaxNOORxXW-GkPqE9eBwjqDzfjy4QVde7xLMfusUvT0uXufLYt09reYP68JSLmghiGFO14Z708iKSqCOOetqycePOG9829a0bXjrjaVSaqeFrT0zrZXcCcurKVqduS7orfqM_V7HbxV0r06DEDdKx9zbHSjmjLAgJfNe1I46U0vRcNYQVwFYDSOrPrNsDClF8H88StTJsTo6VkfHY1ZEqtFx9QN7dW-0</recordid><startdate>20220908</startdate><enddate>20220908</enddate><creator>Dankiewicz, Sara</creator><creator>Bróż, Sebastian</creator><creator>Żelazny, Przemysław</creator><creator>Filipczak, Joanna</creator><creator>Swora, Aleksandra</creator><creator>Borowik, Joanna</creator><creator>Sygacz, Oliwer</creator><creator>Brodowski, Wojciech</creator><creator>Pawłowski, Piotr</creator><creator>Basta-Arciszewska, Katarzyna</creator><general>Kazimierz Wielki University</general><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0756-387X</orcidid><orcidid>https://orcid.org/0000-0002-6171-0386</orcidid><orcidid>https://orcid.org/0000-0002-3512-8368</orcidid><orcidid>https://orcid.org/0000-0002-7759-1588</orcidid><orcidid>https://orcid.org/0000-0003-3245-945X</orcidid><orcidid>https://orcid.org/0000-0001-6794-9112</orcidid><orcidid>https://orcid.org/0000-0002-6191-2535</orcidid><orcidid>https://orcid.org/0000-0002-9208-8462</orcidid><orcidid>https://orcid.org/0000-0001-8369-6207</orcidid><orcidid>https://orcid.org/0000-0002-1197-7218</orcidid></search><sort><creationdate>20220908</creationdate><title>Ormond's disease - the current state of knowledge about diagnosis and treatment</title><author>Dankiewicz, Sara ; Bróż, Sebastian ; Żelazny, Przemysław ; Filipczak, Joanna ; Swora, Aleksandra ; Borowik, Joanna ; Sygacz, Oliwer ; Brodowski, Wojciech ; Pawłowski, Piotr ; Basta-Arciszewska, Katarzyna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1571-70b2da4b5fb69319e1d2dcd495775556f88418658fbc199ada7c4f2b8c95d7c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>glucocorticosteroid therapy</topic><topic>IgG4-related disease</topic><topic>immunosuppressive treatment</topic><topic>Ormond's disease</topic><topic>retroperitoneal fibrosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dankiewicz, Sara</creatorcontrib><creatorcontrib>Bróż, Sebastian</creatorcontrib><creatorcontrib>Żelazny, Przemysław</creatorcontrib><creatorcontrib>Filipczak, Joanna</creatorcontrib><creatorcontrib>Swora, Aleksandra</creatorcontrib><creatorcontrib>Borowik, Joanna</creatorcontrib><creatorcontrib>Sygacz, Oliwer</creatorcontrib><creatorcontrib>Brodowski, Wojciech</creatorcontrib><creatorcontrib>Pawłowski, Piotr</creatorcontrib><creatorcontrib>Basta-Arciszewska, Katarzyna</creatorcontrib><collection>CrossRef</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Journal of education, health and sport</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dankiewicz, Sara</au><au>Bróż, Sebastian</au><au>Żelazny, Przemysław</au><au>Filipczak, Joanna</au><au>Swora, Aleksandra</au><au>Borowik, Joanna</au><au>Sygacz, Oliwer</au><au>Brodowski, Wojciech</au><au>Pawłowski, Piotr</au><au>Basta-Arciszewska, Katarzyna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ormond's disease - the current state of knowledge about diagnosis and treatment</atitle><jtitle>Journal of education, health and sport</jtitle><date>2022-09-08</date><risdate>2022</risdate><volume>12</volume><issue>9</issue><spage>599</spage><epage>606</epage><pages>599-606</pages><issn>2391-8306</issn><eissn>2391-8306</eissn><abstract>Introduction: Retroperitoneal fibrosis (Ormond's disease; RPF) is a rare condition characterized by chronic inflammation and resulting progressive fibrosis of the retroperitoneal space. Due to its low prevalence and uncharacteristic symptoms, it is often overlooked in the diagnostic process, resulting in a late-stage diagnosis when complications are already present and treatment options are limited.
The aim of the study: The purpose of our study was to present, based on the available literature, the latest reports on the diagnosis and treatment of Ormond disease.
State of knowledge: The diagnosis of RPF is based on an anamnesis and imaging. Sometimes a surgical biopsy of the fibrous tissue is necessary. The pathogenesis remains partly unclear. There is no characteristic laboratory marker for early diagnosis of the disease. It is important to distinguish the primary form from the secondary form, in which the trigger factors are known. In therapy, steroid therapy is still the standard. Attempts are being made to treat with other immunosuppressants and biologic drugs with good results, which speaks to the autoimmune basis of the disease. In some cases, surgical treatment and removal of fibrous tissue compressing abdominal structures is essential.
Summary: Although the state of knowledge about retroperitoneal fibrosis has been greatly expanded in recent years, many questions remain to be clarified, especially about its pathogenesis and possible early clinical clues to facilitate diagnosis.</abstract><pub>Kazimierz Wielki University</pub><doi>10.12775/JEHS.2022.12.09.071</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-0756-387X</orcidid><orcidid>https://orcid.org/0000-0002-6171-0386</orcidid><orcidid>https://orcid.org/0000-0002-3512-8368</orcidid><orcidid>https://orcid.org/0000-0002-7759-1588</orcidid><orcidid>https://orcid.org/0000-0003-3245-945X</orcidid><orcidid>https://orcid.org/0000-0001-6794-9112</orcidid><orcidid>https://orcid.org/0000-0002-6191-2535</orcidid><orcidid>https://orcid.org/0000-0002-9208-8462</orcidid><orcidid>https://orcid.org/0000-0001-8369-6207</orcidid><orcidid>https://orcid.org/0000-0002-1197-7218</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2391-8306 |
ispartof | Journal of education, health and sport, 2022-09, Vol.12 (9), p.599-606 |
issn | 2391-8306 2391-8306 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_2db7ce992ff74d1db49765260d3eecae |
source | Open Access: DOAJ - Directory of Open Access Journals |
subjects | glucocorticosteroid therapy IgG4-related disease immunosuppressive treatment Ormond's disease retroperitoneal fibrosis |
title | Ormond's disease - the current state of knowledge about diagnosis and treatment |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A42%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ormond's%20disease%20-%20the%20current%20state%20of%20knowledge%20about%20diagnosis%20and%20treatment&rft.jtitle=Journal%20of%20education,%20health%20and%20sport&rft.au=Dankiewicz,%20Sara&rft.date=2022-09-08&rft.volume=12&rft.issue=9&rft.spage=599&rft.epage=606&rft.pages=599-606&rft.issn=2391-8306&rft.eissn=2391-8306&rft_id=info:doi/10.12775/JEHS.2022.12.09.071&rft_dat=%3Cdoaj_cross%3Eoai_doaj_org_article_2db7ce992ff74d1db49765260d3eecae%3C/doaj_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1571-70b2da4b5fb69319e1d2dcd495775556f88418658fbc199ada7c4f2b8c95d7c53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |